She Fought the FDA for Women’s Sexual Pleasure and Won. Now, Paramount+ Is Telling Her Story.

In exclusive interviews, the filmmakers behind 'The Pink Pill' documentary share how they brought the fight for FDA approval ...
WebMD

Addyi: FDA Approves New Treatment for Low Sexual Desire in Postmenopausal Women

What Is Addyi, and Why Does It Matter? Addyi (flibanserin) is a nonhormonal prescription pill that is now approved by the FDA to treat low sexual desire in women younger than 65, including those who ...
Yahoo

Meet the Addyi Pill—a.k.a. Pink Viagra: Why the FDA's New 2025 Approval Is a ‘Historic First’ for Women Over 50

Add Yahoo as a preferred source to see more of our stories on Google. Viagra, the little blue pill, has been a household name for more than a generation. And now women’s sexual health is finally ...
Monthly Prescribing Reference

Addyi Indication Expanded to Include Postmenopausal Women With HSDD

Credit: Sprout Pharmaceuticals The approval was based on a randomized, double-blind, placebo-controlled phase 3 trial, which included 447 postmenopausal women with acquired, generalized HSDD.
Morningstar

Sprout Pharmaceuticals' Addyi® (flibanserin) Named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards

RALEIGH, N.C., Jan. 29, 2026 /PRNewswire/ -- Sprout Pharmaceuticals today announced that Addyi® has been named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards, one of the ...